VAXCYTE INC (PCVX:NASDAQ)
$59.835 -1.32 (-2.1584%)
Analysed VAXCYTE INC (PCVX:NASDAQ) News Sources
Trevi Therapeutics Is Up 100%, Pivotal bioVenture Adds Anyway. Here's Why That Matters.
03-06-2026
fool.com
Vaxcyte (PCVX) Conducts Initial Dosage for VAX-A1 Phase 1 Study
17-06-2026
yahoo.com
Pneumonia Market Set to Witness Robust Growth During the Forecast Period (2026-2036), Driven by Advancing Therapeutics and Rising Disease Burden | DelveInsight
08-06-2026
yahoo.com
ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer
11-08-2026
yahoo.com
Vaxcyte (PCVX) Completes Enrollment for Phase 3 VAX-31 Clinical Trials
29-05-2026
yahoo.com
Vaxcyte (PCVX) Doses Its First Patient in a Trial for a Disease With No Existing Vaccine
22-06-2026
yahoo.com
Vaxcyte Inc (PCVX) Is A Hidden Multibagger Stock To Buy Now
03-07-2026
yahoo.com
Vaxcyte Reports Second Quarter 2026 Financial Results and Provides Business Update
05-08-2026
yahoo.com
If You Followed Seth Klarman Into Vaxcyte in May, He Was Already Long Gone
16-08-2026
247wallst.com
Vaxcyte to Participate in Upcoming Investor Conferences
27-08-2026
yahoo.com
What is the current price of VAXCYTE INC (PCVX:NASDAQ)?
The current price of VAXCYTE INC (PCVX:NASDAQ) is $59.835.
VAXCYTE INC (PCVX:NASDAQ) absolute price change since previous trading day?
The absolute price change of VAXCYTE INC (PCVX:NASDAQ) since the previous trading day is $-1.32.
VAXCYTE INC (PCVX:NASDAQ) percentage price change since previous trading day?
The percentage price change of VAXCYTE INC (PCVX:NASDAQ) since the previous trading day is -2.1584%.
What is the most recent average sentiment score for VAXCYTE INC (PCVX:NASDAQ)?
The most recent average sentiment score for VAXCYTE INC (PCVX:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for VAXCYTE INC (PCVX:NASDAQ)?
The most recent sentiment for VAXCYTE INC (PCVX:NASDAQ) is .
SEC-8K** Filing Available For VAXCYTE INC (PCVX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.